Clinical Trial Update: Convalescent Plasma for Patients With COVID-19: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating convalescent plasma in patients with COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus
• Coronavirus Infection

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Universidad del Rosario | Conditions: Coronavirus, Coronavirus Infection | Phase 2 | Status: COMPLETED